Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Obstet Gynecol. 2018 Sep;132(3):612–618. doi: 10.1097/AOG.0000000000002787

Table 2.

Reported side effects by treatment group

Side effects Pregabalin
(n=55)
Placebo
(n=52)
P-value
Ever experienced
 Nausea 43 (78.2%) 42 (80.8%) 0.74
 Vomiting 28 (50.9%) 30 (58.8%) 0.41
 Sleepy 47 (85.5%) 39 (76.5%) 0.24
 Dizzy 45 (81.8%) 26 (50%) <0.01
 Headache 28 (50.9%) 17 (33.3%) 0.07
 Blurred vision 15 (27.3%) 7 (13.7%) 0.09
 Diarrhea 28 (50.9%) 29 (56.9%) 0.54
 Constipation 6 (10.9%) 15 (29.4%) <0.02
 Dry mouth 22 (40%) 25 (48.1%) 0.40
After study capsule
 Nausea 37 (67.3%) 38 (73.1%) 0.51
 Vomiting 20 (36.4%) 25 (49%) 0.19
 Sleepy 47 (85.5%) 35 (68.6%) <0.04
 Dizzy 45 (81.8%) 22 (42.3%) <0.01
 Headache 17 (30.9%) 15 (29.4%) 0.87
 Blurred vision 15 (27.3%) 6 (11.8%) <0.05
 Diarrhea 25 (45.5%) 28 (54.9%) 0.33
 Constipation 5 (9.1%) 11 (21.6%) 0.07
 Dry mouth 21 (38.2%) 21 (40.4%) 0.82

Data are n (%).